Xamoterol
Top View
- Marrakesh Agreement Establishing the World Trade Organization
- The Role of Stress, Glucocorticoids & Β-Adrenergic
- Predicting in Vivo Cardiovascular Properties of -Blockers from Cellular Assays: a Quantitative Comparison of Cellular and Cardiovascular Pharmacological Responses
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Customs Tariff - Schedule Xxi - 1
- Repurposing of Drugs As Novel Influenza Inhibitors from Clinical Gene
- Syncope in Patients with Autonomic Nervous System Disturbances:Which Diagnosis and Treatment?
- Human Neurogenesis Assay: Ramelteon
- Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
- An Assessment of the Partial Agonist Activity Ofro 31
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- The Increase in Β-Adrenergic Receptors in Lymphocytes
- Ligands of Adrenergic Receptors: a Structural Point of View
- (12) United States Patent (10) Patent No.: US 8,480,637 B2 Ferrari Et Al
- Clinical Pharmacologyand Therapeutics
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Direct Intra-Cardiomuscular Transfer of 2-Adrenergic Receptor Gene Augments Cardiac Output in Cardiomyopathic Hamsters